Forschungszentrum Borstel
Records under this name other than patents Forschungszentrum Borstel holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Forschungszentrum Borstel
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,068,186 | Viable Gram Negative Bacteria Lacking Outer Membrane Agonists of TLR4/MD-2 Formerly held In force · High confidence | In force | High confidence | |
| US 9,458,454 | Viable Gram Negative Bacteria with Reduced Proteolytic Activity Lacking Outer Membrane Agonists of TLR4/MD-2 Formerly held In force · High confidence | In force | High confidence | |
| US 9,750,796 | Cell wall polymers of Enterococcus faecalis and uses thereof Formerly held Lapsed on the fee record Ended Sep 5, 2025 · USPTO record | Lapsed on the fee record | Ended Sep 5, 2025 | USPTO record |
| US 8,501,199 | Synthetic blocking reagents Lapsed on the fee record Ended Aug 6, 2025 · USPTO record | Lapsed on the fee record | Ended Aug 6, 2025 | USPTO record |
| US 9,255,157 | Rhamno-polysaccharide from Enterococcus faecium clonal complex 17 and uses thereof Formerly held Lapsed on the fee record Ended Feb 9, 2024 · USPTO record | Lapsed on the fee record | Ended Feb 9, 2024 | USPTO record |
| US 9,005,622 | Cell wall components of enterococci and uses thereof Lapsed on the fee record Ended Apr 14, 2023 · USPTO record | Lapsed on the fee record | Ended Apr 14, 2023 | USPTO record |
| US 9,950,017 | Pharmaceutical composition for protection from allergies and inflammatory disorders Formerly held Lapsed on the fee record Ended Apr 24, 2022 · USPTO record | Lapsed on the fee record | Ended Apr 24, 2022 | USPTO record |
| US 7,431,685 | Method and device for investigating substance libraries Lapsed on the fee record Ended Oct 7, 2020 · USPTO record | Lapsed on the fee record | Ended Oct 7, 2020 | USPTO record |
| US 9,375,444 | Composition for prevention and treatment of allergic and/or inflammatory diseases Lapsed on the fee record Ended Jun 28, 2020 · USPTO record | Lapsed on the fee record | Ended Jun 28, 2020 | USPTO record |
| US 6,777,194 | Monoclonal Antibodies Against Human Protein MCM3, Process for Their Production, and Their Use Formerly held Lapsed on the fee record Ended Aug 17, 2016 · High confidence | Lapsed on the fee record | Ended Aug 17, 2016 | High confidence |